• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global generic oncology drug market size reached US$ 22.6 Billion in 2018. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the same active ingredients as the already marketed brand-name cancer care medicine. These drugs can be characterized by a different color or flavor than that of the original drug but their quality, performance, intended use, strength, dosage form and route of administration remain the same. Consequently, these drugs efficiently deliver equivalent clinical benefits and yield the same therapeutic effect as their brand-name counterparts at a lower cost.

The escalating prevalence of cancer is one of the key factors driving the market growth. Owing to various factors including a rapid increase in the number of smokers, sedentary lifestyle and excessive exposure to ultraviolet (UV) rays, the number of cancer cases has experienced a significant rise across the globe. In addition to this, the high costs associated with a full-length cancer treatment have led a majority of the patients to opt for these drugs as they are much more cost-effective as compared to their brand-name counterparts. Moreover, patent expiration of key blockbuster drugs is also a significant factor that is providing a boost to the market growth. Along with this, governments of several countries are undertaking initiatives to promote generic drugs. They are continually engaging in research and development (R&D) activities to reduce healthcare expenses related to cancer treatment, thus making the healthcare facility accessible and affordable for all. Such initiatives are augmenting the introduction of several new generic drugs. Other factors such as rising awareness about the benefits of early cancer diagnosis and growing inclination toward preventive measures are contributing to the market growth. On account of the aforementioned factors, IMARC Group estimates the market to grow at a CAGR of 9.6% during 2019-2024, reaching a value of US$ 39.4 Billion by 2024.

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America


Amongst these, North America holds the leading position in the market, owing to an increasing number of cancer patients and rising awareness about early cancer diagnosis.

Competitive Landscape:

The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players operating in the market.

Key Questions Answered in This Report:

  • How has the generic oncology drug market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic oncology drug industry?
  • What are the various stages in the value chain of the generic oncology drug industry?
  • What are the key driving factors and challenges in the generic oncology drug industry?
  • How has the generic oncology drug market performed so far and how will it perform in the coming years?
  • What is the structure of the generic oncology drug industry and who are the key players?
  • What is the degree of competition in the generic oncology drug industry?
  • What are the profit margins in the generic oncology drug industry?
  • What are the key requirements for setting up generic oncology drug manufacturing plant?
  • How are generic oncology drugs manufactured?
  • What are the various unit operations involved in a generic oncology drug manufacturing plant?
  • What is the total size of land required for setting up a generic oncology drug manufacturing plant?
  • What are the machinery requirements for setting up a generic oncology drug manufacturing plant?
  • What are the raw material requirements for setting up a generic oncology drug manufacturing plant?
  • What are the packaging requirements for generic oncology drugs?
  • What are the transportation requirements for generic oncology drugs?
  • What are the utility requirements for setting up a generic oncology drug manufacturing plant?
  • What are the manpower requirements for setting up a generic oncology drug manufacturing plant?
  • What are the infrastructural costs for setting up a generic oncology drug manufacturing plant?
  • What are the capital costs for setting up a generic oncology drug manufacturing plant?
  • What are the operational costs for setting up a generic oncology drug manufacturing plant?
  • What will be the income and expenditures for a generic oncology drug manufacturing plant?
  • What is the time required to break-even?

1    Preface
2    Scope and Methodology
    2.1     Objectives of the study
    2.2     Stakeholders
    2.3     Data Sources
        2.3.1     Primary Sources
        2.3.2     Secondary Sources
    2.4     Market Estimation
        2.4.1     Bottom-Up Approach
        2.4.2     Top-Down Approach
    2.5     Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview    
    4.2    Key Industry Trends
5    Global Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Region
    5.4    Market Forecast
6    Global Generic Oncology Drug Market
    6.1    Market Overview
    6.2    Market Trends
    6.3    Top Generic Oncology Drugs
    6.4    Price Analysis
    6.5    Market Forecast
    6.6    SWOT Analysis
        6.6.1    Strengths
        6.6.2    Weaknesses
        6.6.3    Opportunities
        6.6.4    Threats
    6.7    Value Chain Analysis
        6.7.1    Research and Development
        6.7.2    Manufacturing
        6.7.3    Marketing
        6.7.4    Distribution
    6.8    Porter’s Five Forces Analysis
        6.8.1    Overview
        6.8.2    Bargaining Power of Buyers
        6.8.3    Bargaining Power of Suppliers
        6.8.4    Degree of Competition
        6.8.5    Threat of New Entrants
        6.8.6    Threat of Substitutes
        6.8.7    Regulations in the Generics Industry
    6.9    Key Market Drivers and Success Factors
7    Global Generic Oncology Drug Market: Performance of Key Regions
    7.1    North America
    7.2    Europe
    7.3    Asia Pacific
    7.4    Middle East and Africa
    7.5    Latin America
8    Global Generic Oncology Drug Market: Competitive Landscape
    8.1    Competitive Structure
    8.2    Market Breakup by Key Players
    8.3    Key Player Profiles
 9    Generic Oncology Drug Manufacturing Process
    9.1    Product Overview
    9.2    Detailed Process Flow (Tablets)
    9.3    Detailed Process Flow (Injectable)
    9.4    Various Types of Unit Operations Involved
    9.5    Mass Balance and Raw Material Requirements
10    Project Details, Requirements and Costs Involved
    10.1    Land Requirements and Expenditures
    10.2    Construction Requirements and Expenditures
    10.3    Plant Machinery
    10.4    Machinery Pictures
    10.5    Raw Material Requirements and Expenditures
    10.6    Packaging Requirements and Expenditures
    10.7    Transportation Requirements and Expenditures
    10.8    Utility Requirements and Expenditures
    10.9    Manpower Requirements and Expenditures
    10.10    Other Capital Investments
11    Loans and Financial Assistance
12    Project Economics

    12.1    Capital Cost of the Project
    12.2    Techno-Economic Parameters
    12.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    12.4    Taxation and Depreciation
    12.5    Income Projections
    12.6    Expenditure Projections
    12.7    Financial Analysis
    12.8    Profit Analysis
 
List of Figures

Figure 1: Global: Generic Drug Industry Overview
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2010 – 2017
Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2018 – 2023
Figure 4: Global: Generic Drug Market: Breakup by Region (in %), 2017
Figure 5: Global: Generic Oncology Drug Industry Overview
Figure 6: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2010 – 2017
Figure 7: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2018 – 2023
Figure 8: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2017
Figure 9: Global: Generic Oncology Drug Industry: SWOT Analysis
Figure 10: Global: Generic Oncology Drug Industry: Value Chain Analysis
Figure 11: Global: Generic Oncology Drug Industry: Porter’s Five Forces Analysis
Figure 12: North America: Generic Oncology Drug Market (in Million US$), 2010, 2017 & 2023
Figure 13: Asia Pacific: Generic Oncology Drug Market (in Million US$), 2010, 2017 & 2023
Figure 14: Europe: Generic Oncology Drug Market (in Million US$), 2010, 2017 & 2023
Figure 15: Latin America: Generic Oncology Drug Market (in Million US$), 2010, 2017 & 2023
Figure 16: Middle East and Africa: Generic Oncology Drug Market (in Million US$), 2010, 2017 & 2023
Figure 17: Generic Oncology Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 18: Generic Oncology Drug Manufacturing: Production Cost Breakup (in %)
Figure 19: Generic Oncology Drug Manufacturing Plant: Detailed Process Flow
Figure 20: Generic Oncology Drug Manufacturing Process: Conversion Rate of Feedstocks
Figure 21: Generic Oncology Drug Manufacturing Plant: Proposed Plant Layout
Figure 22: Generic Oncology Drug Manufacturing Plant: Breakup of Capital Costs (in %)
 
List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2017 and 2023
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2018-2023
Table 3: Global: Generic Oncology Drug Market: Key Industry Highlights, 2017 and 2023
Table 4: Generic Oncology Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Oncology Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Oncology Drug Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 7: Generic Oncology Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Oncology Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Oncology Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Oncology Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Oncology Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Oncology Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Oncology Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Oncology Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Oncology Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Oncology Drug Manufacturing Plant: Profit and Loss Account

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links